Key Highlights
- Rocket Lab successfully executed its maiden dedicated mission for the European Space Agency (ESA) on March 28.
- The “Daughter Of The Stars” mission placed ESA’s “Celeste” payload into a 510 km low Earth orbit.
- This represented RKLB’s sixth mission of 2026 and the 85th Electron rocket flight to date.
- The company secured a record-breaking $190 million U.S. Department of War agreement for 20 hypersonic test missions, elevating its total backlog beyond $2 billion.
- Analysts maintain a Moderate Buy rating on RKLB with a consensus price target of $89.36, suggesting approximately 47% potential upside.
Rocket Lab achieved a significant milestone Friday evening by executing its inaugural dedicated European Space Agency mission, deploying a pair of navigation satellites from its New Zealand launch facility. The Electron launch vehicle departed from Launch Complex 1 at 10:14 p.m. New Zealand time on March 28, transporting ESA’s “Celeste” payload to a 510-kilometer altitude in low Earth orbit.
Dubbed “Daughter Of The Stars,” this mission represents the company’s sixth orbital delivery of 2026 and brings the Electron rocket’s total mission count to 85.
The satellite pair will conduct tests to determine whether a low Earth orbit constellation can effectively complement Europe’s Galileo navigation infrastructure, which functions in medium Earth orbit. The objective involves enhancing positioning precision throughout Europe for applications spanning autonomous transportation, maritime operations, and emergency response systems.
The spacecraft were manufactured by two separate European partnerships — one headed by GMV based in Spain and another led by Thales Alenia Space from France.
RKLB stock advanced approximately 2% during Monday’s premarket session after the mission announcement.
Shares have declined 13% since the beginning of the year, affected by widespread risk-averse market sentiment and continuing U.S.-Iran tensions. Despite this, the stock has surged 231% over the trailing twelve months.
Major Defense Contract Strengthens Position
In addition to this orbital achievement, Rocket Lab recently finalized a $190 million agreement with the U.S. Department of War covering 20 hypersonic test missions utilizing its HASTE launch platform. This represents the organization’s most substantial individual contract to date.
This arrangement elevated Rocket Lab’s cumulative backlog above the $2 billion threshold.
For the remainder of 2026, the company’s manifest includes missions spanning commercial Earth observation platforms, national security payloads, international space agency clients, and hypersonic technology demonstrations.
Neutron Rocket Remains Key Catalyst
These operational achievements precede the highly anticipated inaugural flight of Rocket Lab’s more capable Neutron launch system, presently scheduled for late 2026.
Neutron aims to compete within the medium-lift segment, focusing on reusable launch capabilities for expanded commercial and government payload requirements.
Analysts maintain a Moderate Buy consensus rating on RKLB, supported by nine Buy recommendations and four Hold ratings. The average price objective stands at $89.36 — indicating approximately 47% upside potential from present trading levels.


